In a world where innovation and resilience redefine success, certain entrepreneurs stand out for their unmatched vision, ...
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T ...